Related references
Note: Only part of the references are listed.Clinical proteomics of myeloid leukemia
Sigrun M. Hjelle et al.
GENOME MEDICINE (2010)
Valproic Acid Activates the PI3K/Akt/mTOR Pathway in Muscle and Ameliorates Pathology in a Mouse Model of Duchenne Muscular Dystrophy
Praveen B. Gurpur et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia
Anne Margrete Oyan et al.
BMC CANCER (2009)
Targeted therapy in acute myeloid leukaemia: current status and future directions
Camilla Stapnes et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate
A. Poggi et al.
LEUKEMIA (2009)
A subset of patients with high-risk acute myelogenous leukemia shows improved peripheral blood cell counts when treated with the combination of valproic acid, theophylline and all-trans retinoic acid
Anita Ryningen et al.
LEUKEMIA RESEARCH (2009)
Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia
Marco Montillo et al.
LEUKEMIA RESEARCH (2009)
In vivo biological effects of ATRA in the treatment of AML
Anita Ryningen et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Valproic Acid and All-Trans Retinoic Acid: Meta-Analysis of a Palliative Treatment Regimen in AML and MDS Patients
Frauke Bellos et al.
ONKOLOGIE (2008)
A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia
Nina Anensen et al.
CLINICAL CANCER RESEARCH (2006)
Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling
PO Krutzik et al.
NATURE METHODS (2006)
Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia
G Bug et al.
CANCER (2005)
Valproic acid II: Effects on oxidative stress, mitochondrial membrane potential, and cytotoxicity in glutathione-depleted rat hepatocytes
V Tong et al.
TOXICOLOGICAL SCIENCES (2005)
Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways
A Glasow et al.
BLOOD (2005)
Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid
A Kuendgen et al.
BLOOD (2004)
Single cell profiling of potentiated phospho-protein networks in cancer cells
JM Irish et al.
CELL (2004)
Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)
PH Wiernik et al.
LEUKEMIA (2004)
Complete β-oxidation of valproate:: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase
MFB Silva et al.
BIOCHEMICAL JOURNAL (2002)
Flow cytometric measurement of apoptosis and necrosis in cryopreserved PBPC concentrates from patients with malignant diseases
JF Abrahamsen et al.
BONE MARROW TRANSPLANTATION (2002)
Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival
M Benekli et al.
BLOOD (2002)
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
M Göttlicher et al.
EMBO JOURNAL (2001)
Share Paper
